+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Small-Cell Lung Cancer (NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Gorlin-syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gorlin-syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 85 Pages
  • Global
From
Brain Metastasis - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Desmoid Tumors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Familial Adenomatous Polyposis - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Adenomatous Polyposis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peritoneal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Anaplastic Astrocytomas - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Glioblastoma - Pipeline Insight, 2025 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Castleman Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Castleman Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
High-Grade Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more